Berkeley Speakers

Barcelona Speakers

 

     

 

Past and Current Speakers at the California Session

University of California's distinguished faculty is engaged in advanced research and is in constant dialogue with executives who are leading their industries. These activities ensure that you are immersed in the most critical and contemporary issues. Through this interaction, you'll learn to recognize the types of information and intuition that stimulate effective implementation of health care strategy and vision in organizations and countries. We are grateful to our guest speakers, well-known health care leaders, who have agreed to join us in our quest to advance the state of knowledge regarding effective health care policies and management.

_____________________________________

Featured Speakers for upcoming 2012 session

Sir Richard G. A. Feachem,
K.B.E., C.B.E., B.Sc., Ph.D., D.Sc. (Med), F.R.Eng., F.I.C.

Sir Richard G. A. Feachem,  K.B.E., B.Sc., F.R.Eng., Ph.D., D.Sc. (Med), F.I.C.

Jason Cheah, M.D.

Jason Cheah, M.D.

Dov Chernichovsky, Ph.D., M.A.

Dov Chermichovsky, Ph.D., M.A.

Dominic Montagu, Ph.D., M.P.H., M.B.A.

Dominic Montagu, Ph.D.,M.P.H., M.B.A.

Neelam Sekhri Feachem, M.H.A.

Neelam Sekhri Feachem, M.H.A.

Mark Smith, M.D., M.B.A.

Mark Smith, M.D., M.B.A.

Video of Mark Smith on Healthcare Reform

 

Gavin Yamey, M.D., M.P.H., M.A., M.R.C.P.

Arnold Milstein

_____________________________________

Peter Berman, Ph.D.

Lead Health Economist, World Bank's HNP anchor department. Adjunct Professor of Population and International Health at Harvard School of Public Health.

Peter Berman

Health economist with thirty years of experience in research, policy analysis and development, and training and education in global health. Specific areas of technical expertise include analysis of health systems performance and the design of reform strategies; assessment of the supply side of health care delivery and the role of private health care provision in health systems and development of strategies to improve outcomes through public-private sector collaboration; and the use of national health accounts as a policy and planning tool. Worked extensively on health system reform issues in a number of countries, including Egypt, India, Colombia, Indonesia, and Poland.

 

Bruce Bodaken

President, Chairman, and CEO, Blue Shield of California

Bruce Bodaken

 

Simone Buitendijk, M.D., M.P.H., Ph.D.

Head, Child Health Programme at The Netherlands Institute for Applied Scientific Research, the Netherlands/ Leiden University Medical Center
GHLF Alumna

 

Simone Buitendijk, M.D., M.P.H., Ph.D.

 

Jennifer Chatman, Ph.D.

Director, Haas School of Business, Ph.D. Program, UC Berkeley
Paul J. Cortese Distinguished Professor of Management
Haas Organizational Behavior and Industrial Relations Group
Well-known for leadership training of executives.

Jennifer Chatman, Ph.D.

 

Jason Cheah, M.D.

Appointed by the Ministry of Health Singapore as CEO of a new National Agency for Integrated Care (AIC).

Jason Cheah, M.D.

 

Dov Chernichovsky, M.A., Ph.D.

Lecturer and Professor of Health Sciences, Department of Health Policy and Management, Ben-Gurion University of the Negev, Israel, Consultant, World Bank, Washington DC. Health system adviser to the Israeli Parliament, heads the Health Team at the Taub Centre for Social Policy Studies in Israel, and is a Research Associate with the National Bureau of Economic Research (NBER).

Dov Chernichovsky, M.A., Ph.D.

 

Molly Joel Coye, M.D., M.P.H.

Founder and CEO, Health Technology Center (HealthTech). Founder and CEO of The Health Technology Center, a non-profit education and research organization established in 2000 to advance the use of beneficial technologies in promoting healthier people and communities. Previous positions include: Director of the California Department of Health Services, managing a budget of more than $16 billion, 5,000 employees and 160 branch and field offices throughout the state, executive in the Good Samaritan Health System, Director of Product Development and Marketing for HealthDesk Corporation, a developer of consumer software for interactive health communication and disease management.

Molly Joel Coye, M.D., M.P.H.

 

Susan Desmond-Hellmann, M.D., M.P.H.

Chancellor, University of California, San Francisco. Previously, responsible for Genentech's Development, Regulatory Affairs, Quality, Compliance, Product Portfolio Management, Alliance Management, Business Development and Pipeline Strategy Support functions. Board-certified in Internal Medicine and Medical Oncology

Susan Desmond-Hellmann, M.D., M.P.H.

 

John Ellwood, Ph.D.

Professor of Public Policy, UC Berkeley

John Ellwood, Ph.D.

 

Alain C. Enthoven, Ph.D.

Marriner S. Eccles Professor of Public and Private Management, Emeritus, Graduate School of Business, Stanford University. Senior Fellow, Center for Health Policy, Institute of International Relations, Stanford University

Alain C. Enthoven, Ph.D.

 

Sir Richard G. A. Feachem, K.B.E., C.C.E., B.Sc., Ph.D., D.Sc. (Med), F.R.Eng., F.I.C.

Professor of Global Health, University of California, San Francisco and the University of California, Berkeley, Director of the Global Health Group, UCSF Global Health Sciences

Sir Richard G. A. Feachem

Previously: First Executive Director, Global Fund to Fight AIDS, Tuberculosis and Malaria. Undersecretary General, United Nations, Director for Health, Nutrition and Population at the World Bank and Dean of the London School of Hygiene and Tropical Medicine. Worked in international health and development for 30 years and has published extensively on public health and health policy. Knighted by Her Majesty Queen Elizabeth II in 2007 and received honours from the Governments of Niger and Togo.

 

Neelam Sekhri Feachem, M.H.A.

Chief Executive Officer, The Healthcare Redesign Group. Previously, served as health financing and policy advisor at the World Health Organization until 2007, where she provided technical and policy guidance on health financing strategies with a particular focus on private and social insurance, and methods to complement public financing with private funding instruments. Over 25 years of experience in health financing, health systems, health financing and health management.
Strong expertise re: public and private roles of health insurance and public-private partnerships.

Neelam Sekhri Feachem, M.H.A.

 

Harvey Fineberg, M.D., Ph.D.

President, U.S. Institute of Medicine of The National Academies.Professor Emeritus of Health Policy and Management, Department of Health Policy and Management. Served as provost of Harvard University from 1997-2001, following thirteen years as dean of the Harvard School of Public Health.

Harvey Fineberg, M.D., Ph.D.

 

Pamela Garside, MHA

Visiting faculty at Judge Business School, the business school of the University of Cambridge. Co-Director of the Cambridge Programme on Health Leadership.Owner of Newhealth, a management consultancy specialsing in organizational strategy.

Pamela Garside, MHA

 

Jodi Halpern, M.D., Ph.D.

Associate Professor of Bioethics, Joint Medical Program, School of Public Health, UC Berkeley. Known as an expert in the field of health care ethics, with numerous books and publications.

Jodi Halpern, M.D., Ph.D.

 

George Halvorson

Chairman and Chief Executive Officer, Kaiser Foundation Health Plan/Hospitals

George C. Halvorson

 

Chris Ham

CEO, UK King's Fund

Chris Ham

 

Teh-wei Hu, Ph.D.

Professor Emeritus of economics, School of Public Health, UC Berkeley. Expertise in Asian health reform and tobacco management

Teh-wei Hu, Ph.D.

Dean Jamison, Ph.D.

Professor of Global Health, School of Public Health, University of Washington and active in the Institute for Health Metrics and Evaluation. Research interests include: cost-effectiveness; health economics; economics of education; human resources; economic development

Dean Jamison, Ph.D.

 

Meg A. Kellogg, M.S.

Program Director, Global Health Leadership Forum, School of Public Health, UC Berkeley, and Health Care Consultant. Previously, Director of Strategic Planning and Product Development, Kaiser Permanente, Co-editor, Medical Technology Stock Letter and leadership positions in the US Health Care Financing Administration

Meg Kellogg

 

Donald Kemper, M.P.H.

Chairman and CEO, Healthwise, a not-for-profit organization dedicated to helping people make better health decisions. Founding Chair, IxCenter Board of Directors. Mr. Kemper is a passionate advocate for improving patient-physician partnerships through prescription information.
GHLF alumnus

Donald W. Kemper

 

John Kitzhaber, M.D.

Two-term Governor of Oregon, USA

John Kitzhaber, M.D.

 

Kenneth W. Kizer, M.D., M.P.H.

President and CEO of National Quality Forum. Previously served as undersecretary for health in the U.S. Department of Veteran Affairs (VA) and is widely credited for the transformation of VA health care since its creation in 1946.

Kenneth W. Kizer, M.D., M.P.H.

David Lawrence, M.D.

Former CEO and Chairman of Board, Kaiser Foundation Health Plan. Prior to his positions with Kaiser, Dr. Lawrence was Health Officer and Director of Human Services in Multnomah County, Oregon, and served as the Director of MEDEX at the School of Public Health and Community Medicine at the University of Washington. He also served as an advisor to the Ministry of Health of Chile and as a Peace Corps physician in the Dominican Republic and in Washington, D.C.

David Lawrence, M.D.

 

Hal Luft, Ph.D.

Director, Palo Alto Medical Foundation Research Institute. Caldwell B. Esselstyn Professor Emeritus of Health Policy and Health Economics, Philip R. Lee Institute for Health Policy Studies

Hal Luft, Ph.D.

 

Arnold Milstein, M.D.

Medical Director, Pacific Business Group on Health (PBGH). National Health Care Thought Leader, William H. Mercer. Work focuses on improving managed care programs for large purchasers and government.

Arnold Milstein, M.D.

 

Dominic Montagu, Ph.D., M.P.H., M.B.A.

Assistant Professor of Epidemiology and Biostatistics at UCSF and Lead of the Health Systems Initiative at the UCSF Global Health Group.

Arnold Milstein, M.D.

 

Ian Morrison, M.A., Ph.D.

Senior Research Fellow and President Emeritus, Institute for the Future (IFTF). Health Advisory Panel Chair, Institute for the Future's Health Advisory Panel. Founding Partner, Strategic Health Perspectives (SHP).
Internationally known author, consultant and speaker specializing in long-term forecasting and planning with particular emphasis on health care and the changing business environment.

Ian Morrison, M.A., Ph.D.

 

Philip Musgrove, Ph.D.

Deputy Editor for Global Health, Health Affairs Journal. Has worked on health reform projects in Argentina, Brazil, Chile and Colombia, besides dealing with a variety of issues in health economics, financing, equity, nutrition, household income and consumption and natural resources. Previously,From October 2002 to September 2005, an Editor of the Disease Control Priorities Project at the Fogarty International Center of the National Institutes of Health and World Bank Principal Economist.

Philip Musgrove, Ph.D.

 

Robert Pearl, M.D.

Chief Executive Officer, The Permanente Medical Group
Dr. Robert Pearl is responsible for the health care of more than 3.1 million Kaiser Permanente Northern California members. The Permanente Medical Group is composed of approximately 4,400 physicians and 20,000 staff members. Over the past decade, Dr. Pearl has been a leader in implementing advanced information technology systems across Kaiser Permanente.

Robert Pearl, M.D.

 

Edward Penhoet, Ph.D.

President, Gordon & Betty Moore Foundation; Professor of Health Policy & Management . Previously Dean of the School of Public Health, UC Berkeley and Chairman and CEO of Chiron, an early biotechnology company.

Edward Penhoet, Ph.D.

 

Malcolm Potts , Ph.D.

Professor, School of Public Health, University of California, Berkeley. Obstetrician and reproductive scientist. He is the first holder of the Fred H. Bixby endowed chair in Population and Family Planning in the School of Public Health, Berkeley, and has developed the Bixby Center with a team of young experts. First Medical Director of the International Planned Parenthood Federation for a decade, he introduced family planning methods into scores of developing countries. His recent books include Queen Victoria’s Gene and Ever Since Adam and Eve: The Evolution of Human Sexuality, and Sex and War: How Biology Explains War and Terrorism and Offers a Path to a Safer World.Faculty Web Page: Professor Potts

Malcolm Potts, Ph.D

 

Molly Porter

Training Director, Kaiser Permanente International. Develops and implements educational programs about Kaiser Permanente for international visitors. Makes presentations about Kaiser Permanente at international conferences and to international groups visiting California. Countries visited on business in the past year include Brazil, the United Kingdom, the Netherlands, Germany, and Denmark.
Alumna, GHLF

Molly Porter

 

Alexander S. Preker, M.D., Ph.D.

Lead Economist for the Health, Nutrition, and Population, World Bank, responsible for overseeing the Bank's analytical work on health financing and provision.
Faculty Adviser, GHLF

Aalexander S Preker, M.D. Ph.D

 

Thomas Rundall, Ph.D.

Executive Associate Dean, School of Public Health, UC Berkeley. Henry J. Kaiser Professor of Organized Health Systems. One of his areas of expertise: evidence-based management.

Thomas Rundall, Ph.D.

 

Kristiana Raube, Ph.D., M.P.H.

Adjunct Professor and Executive Director, Graduate Program in Health Management

Ph.D., M.P.H.

 

James A. Rice, Ph.D.

Executive Vice President & Practice Leader, Integrated Healthcare Strategies; leads the Governance & Leadership Services practice, focusing his consulting work on strategic governance, visioning for health sector and not-for-profit organizations; leadership development for physicians; strategic capital financial planning; mergers and acquisitions; and enterprise risk management analyses for physician-hospital joint ventures. Also Vice Chairman of The Governance Institute, an organization dedicated to knowledge generation and dissemination via research and education for health system boards and leadership teams. Recognized authority on healthcare policy, governance, and strategy development

James A. Rice

 

James Robinson, Ph.D., M.P.H.

Kaiser Permanente Distinguished Professor of Health Economics, School of Public Health, UC Berkeley; Director, Berkeley Center for Health Technology

James Robinson, Ph.D., M.P.H.

 

Murray Ross, Ph.D.

VP, Kaiser Permanente Institute for Health Policy, Kaiser Permanente Medical Care Program

Alumnus, GHLF

Murray Ross, Ph.D.

 

Richard B. Saltman, Ph.D.

Professor of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, Georgia; Associate Director on Health Care Systems, European Observatory

Richard B. Saltman, Ph.D.

 

William Satariano, Ph.D., M.P.H.

Professor of Epidemiology and Community Health, School of Public Health, UC Berkeley

William Satariano, Ph.D., M.P.H.

 

Leonard Schaeffer

Leonard D. Schaeffer is the founding Chairman & CEO of WellPoint, the nation's largest health insurance company. WellPoint has over 34 million medical members and revenues of over $56 billion. Currently Chairman of Surgical Care Affiliates and a Senior Advisor to TPG Capital, a private equity firm. WellPoint was selected by Fortune as America's Most Admired Health Care Company for six consecutive years. Mr. Schaeffer was selected by BusinessWeek as one of the Top 25 Managers of the Year and by Worth as one of the "50 Best CEOs in America". Public service included appointments as Administrator of the federal Health Care Financing Administration (now CMS), Assistant Secretary for Management and Budget of the federal Department of Health, Education and Welfare.

Leonard D. Schaeffer

 

Onno Schellekens, M.B.A.

Managing Director, PharmAccess, The Netherlands. PharmAccess Foundation is a Dutch not-for-profit organization supporting basic health care including HIV/AIDS treatment and care in Africa. Also founder of the Health Insurance Fund and the Investment Fund for Health in Africa. The Health Insurance Fund (HIF), established in 2005, aims to introduce medical insurance schemes for low- and no-income groups through private healthcare providers.

Onno Schellekens, M.B.A.

 

Richard Scheffler, Ph.D.

Distinguished Professor of Health Economics & Public Policy and Director, Petris Center on Healthcare and the Global Center for Health Economics Research. Areas of expertise include mental health, social capital and human resources in health.
Faculty Director, Global Health Leadership Forum

Richard Scheffler, Ph.D.

 

Stephen Shortell, Ph.D.

Dean, School of Public Health, UC Berkeley and Blue Cross of California, Distinguished Professor of Health Policy & Management. Areas of expertise include quality, physician practices and integration

Stephen Shortell, Ph.D.

 

Mark Smith, M.D., M.B.A.

President and CEO of California HealthCare Foundation, an independent philanthropy with assets of more than $900 million, headquartered in Oakland, California, and dedicated to improving the health of the people of California through its three program areas: Better Chronic Disease Care, Innovations for the Underserved, and Market and Policy Monitor. A board-certified internist, Smith is a member of the clinical faculty at the University of California, San Francisco, and an attending physician at the Positive Health Program for AIDS care at San Francisco General Hospital. He is a member of the Institute of Medicine and serves on the board of the National Business Group on Health.

Mark Smith, M.D., M.B.A

 

Joanne Spetz, Ph.D.

Associate Adjunct Professor, Community Health Systems, University of California, San Francisco, Research and academic interests include nursing labor markets, quality of patient care, hospital industry structure and finance, maternal-child health, statistical and econometric methods, cost effectiveness analysis.

Joanne Spetz, Ph.D.

 

 

Saumya Sutaria, MD

Principal, McKinsey and Company, Silicon Valley. Interests and focus are in the health care sector with emphasis on provider systems. Maintains an associate clinical faculty appointment at the University of California at San Francisco.

Saumya Sutaria, MD

 

Paul Wallace, M.D.

Medical Director for Health and Productivity Management Programs Kaiser Permanente. Combined experiences in clinical medical oncology and hematology practice with work in quality improvement, especially in the areas of performance measurement, evidence based medicine and population based care. Responsibilities include the development and analysis of clinical population-based wellness and health maintenance interventions.

Paul Wallace

 

Julia Walsh , M.D., M.Sc.

Associate Adjunct Professor, School of Public Health, University of California, Berkeley. Research interests include Cost-effectiveness and Cost-Benefit Analysis and using results for resource allocation, forecast potential demand and market size for new interventions, and access to health and family planning through private systems.

Julia Walsh , M.D., M.Sc.

 

 

Andrew M. Wiesenthal, M.D., S.M.

Associate Executive Director of the Permanente Federation for Clinical Information Support. From 1983 until April 2000, Dr. Wiesenthal served as a pediatrician and pediatric infectious disease consultant with the Colorado Permanente Medical Group (CPMG). Current work is in the arenas of development and deployment of automated medical records, decision support, and other clinical systems for all of Kaiser Permanente.

Andrew M. Wiesenthal, M.D., S.M.

Gavin Yamey, M.D., M.A., M.R.C.P.

Lead of E2Pi, the Evidence-to-Policy Initiative at the UCSF Global Health Group

Gavin Yamey, M.D., M.A., M.R.C.P.